<DOC>
	<DOCNO>NCT01467661</DOCNO>
	<brief_summary>The purpose study provide SPD422 subject complete Study SPD422 308 , opinion Investigator , continue benefit treatment .</brief_summary>
	<brief_title>Long-term Safety SPD422 Japanese Adults With Essential Thrombocythaemia</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<mesh_term>Anagrelide</mesh_term>
	<criteria>Subjects must complete Study SPD422 308</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>